Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice
about
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell EngraftmentDonor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell TransplantationPositive and negative regulation by NK cells in cancerGraft failure in the modern era of allogeneic hematopoietic SCT.Marrow-dependent cells depleted by 89Sr mediate genetic resistance to herpes simplex virus type 1 infection in miceNatural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.Role of HLA-G and NCR in protection of umbilical cord blood haematopoietic stem cells from NK cell mediated cytotoxicity.Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.Graft-versus-host reactions in mice. IV. Thymus cell suppression of antibody formation.Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.Haemopoietic stem cells in leukaemic AKR mice: the (AKR x C57BL/6)F1 mouse as an in vivo assay system.Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strainsPeculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.Mechanisms of genetic resistance to friend virus leukemia in mice.Mechanisms of genetic resistance to Friend virus leukemia in mice. IV. Identification of a gene (Fv-3) regulating immunosuppression in vitro, and its distinction from Fv-2 and genes regulating marrow allograft reactivity.Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change.Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J miceGene complementation. Neither Ir-GLphi gene need be present in the proliferative T cell to generate an immune response to Poly(Glu55Lys36Phe9)n.Differentiation from precursors in athymic nude mouse bone marrow of unusual spontaneously cytolytic cells showing anti-self-H-2 specificity and bearing T cell markersDevelopment of adult bone marrow stem cells in H-2-compatible and -incompatible mouse fetuses.Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectorsRejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejectionAcute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognizedMechanisms of genetic resistance to Friend virus leukemia in mice. II. Resistance of mitogen-responsive lymphocytes mediated by marrow-dependent cells.Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effectsNatural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgeneAnalysis of the genetic control of lymphocyte positioning.Potential therapeutic role of natural killer cells in cancer.Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapyCis interactions of immunoreceptors with MHC and non-MHC ligands.Graft failure after allogeneic hematopoietic cell transplantationRole for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cellsCombination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.Hybrid resistance to parental bone marrow transplantation: adaptive modification of hemopoietic stem cell in a nonsyngeneic environment.Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype.Uterine NK cells: active regulators at the maternal-fetal interface.The early days of NK cells: an example of how a phenomenon led to detection of a novel immune receptor system - lessons from a rat modelHost-tumor interactions in the SJL lymphoma model.Mixed lymphocyte reactivity and cell-mediated lympholysis to D-end differences of the murine major histocompatibility complex. Comparison of in vitro responses to exclusive D-end or more extensive MHC differences.
P2860
Q26765845-C6382866-003F-4B4A-8DFF-40E12F733F53Q26767440-EE484459-B3CF-4E67-9C18-8E63894BE1BAQ27004658-48F60FAE-392C-4647-B30E-47218F30F3FAQ33404733-41408CA3-17CB-447B-849C-A65BCDCE4D36Q33904513-550D67B0-9837-486E-96FC-5C0877F091C5Q34093656-61AF3844-BF00-4820-8A47-0B17338DC476Q35377258-03818A63-042A-4A6F-8945-4080B191F510Q35679173-8A2C58D3-27DD-4F16-8E75-DD5E35D9A22CQ35869989-572DAA0D-BC9E-4988-A537-0027F0D80FDDQ35925091-1970CF44-B231-486B-B701-1CB44B301B35Q36046595-D1A318F1-BE3A-46A3-BE12-9CCECBDF4C77Q36271178-D5EA4794-FE24-4610-A726-2EB8A55E7721Q36271368-81CCE5F4-FF82-4A1B-85BA-6FBDA9415198Q36273389-CA763E59-6C6E-43F7-9498-8F3027B5B1DAQ36340714-E4D97FBB-F7F0-470B-9F03-DC26B34F6174Q36341207-B9C48D96-115D-4730-8EF1-C0CDD87FA2FBQ36342783-4D53015C-D911-4FC8-99A0-073A19A23377Q36343326-2DD41D41-FEB1-4DB8-8B50-93454FC3FAB0Q36343676-8BA78DDE-72FC-4979-B79C-5A2EEC231364Q36348189-1AE3078A-88FD-4343-8B20-617C7A329288Q36348533-8B3A6BF9-C9FA-4800-8004-9BEC8D7E5D07Q36348634-29CC643B-D91E-4FAB-A6AC-00CE873D3734Q36353538-40ABA74D-89BA-4E7B-B125-93D58C4E4904Q36357551-EEC4E1A7-6DE0-4F49-8176-3B6E6CDD44F8Q36359267-F3762E60-3615-4757-9A39-07BFF7EE0601Q36380188-3C218E4A-628F-4E08-A517-A1F734E624D4Q36380455-2418477A-271E-43E7-90AC-DB4AB92E8355Q36457559-E5E5B830-8AE9-4A1D-976E-0A445334C7F1Q36675436-CD62A97F-7575-4C21-B8C0-1E2539E5835DQ36719911-0E66B576-CA88-441F-B793-742D410AE76AQ36800512-EC935FD5-2C16-4A7D-B28C-79D79941207FQ37045988-7ACEC93B-2BD1-4C7E-9269-41D381CDDD5DQ37189816-B7611DE2-DBCA-43AB-996E-84259DD1E938Q37327064-AFFD3777-ADF3-420E-85EC-A7D4E7EF4D47Q37334177-5AC76D3A-7320-4589-859B-B8A821393A02Q37608955-6FDD13C6-1785-4687-9BD5-8B8F2E52D09FQ37726609-A0EBE636-96B1-4092-A806-6C200C397469Q38225120-4F055258-A804-4F5B-ABC9-8F9A069B1C14Q39706081-49003CAE-5550-46FC-B5E6-2717A412B341Q39777449-80116D77-F78A-4EA8-A91E-DB1066B8EAA9
P2860
Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh
1971年學術文章
@zh-hant
name
Peculiar immunobiology of bone ...... n by irradiated responder mice
@ast
Peculiar immunobiology of bone ...... n by irradiated responder mice
@en
type
label
Peculiar immunobiology of bone ...... n by irradiated responder mice
@ast
Peculiar immunobiology of bone ...... n by irradiated responder mice
@en
prefLabel
Peculiar immunobiology of bone ...... n by irradiated responder mice
@ast
Peculiar immunobiology of bone ...... n by irradiated responder mice
@en
P2860
P356
P1476
Peculiar immunobiology of bone ...... n by irradiated responder mice
@en
P2093
Cudkowicz G
P2860
P304
P356
10.1084/JEM.134.1.83
P407
P577
1971-07-01T00:00:00Z